Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100000130
HKD
2.23
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
955.37
929.91
978.66
850.22
699.22
732.38
767.14
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
955.37
929.91
978.66
850.22
699.22
732.38
767.14
Raw Material Cost
212.41
284.54
225.08
151.19
102.83
121.93
136.68
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
117.68
112.59
170.28
142.24
152.22
251.94
146.16
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
2.20
0.57
0.55
0.41
0.80
0.14
0.06
Selling and Distribution Expenses
518.51
481.62
570.84
524.20
444.04
441.41
459.99
Other Expenses
-7.17
-9.87
-14.87
-11.79
-11.57
-23.89
-14.58
Total Expenditure (Excl Depreciation)
779.07
780.63
818.08
700.20
584.17
576.53
597.06
Operating Profit (PBDIT) excl Other Income
176.29999999999998
149.3
160.6
150
115
155.9
170.10000000000002
Other Income
44.22
70.78
82.34
59.96
52.79
41.55
50.87
Operating Profit (PBDIT)
249.95
250.51
281.99
246.62
193.84
223.08
243.85
Interest
2.20
0.57
0.55
0.41
0.80
0.14
0.06
Exceptional Items
6.28
-0.35
-12.87
2.25
0.47
0.00
-0.19
Gross Profit (PBDT)
742.96
645.37
753.59
699.03
596.39
610.45
630.46
Depreciation
29.43
30.45
39.08
34.80
24.90
24.18
22.91
Profit Before Tax
224.61
219.14
229.49
213.65
168.60
198.77
220.69
Tax
24.84
55.37
4.40
40.97
26.39
34.66
29.74
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
199.77
163.77
225.09
172.69
142.21
164.11
190.95
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
199.77
163.77
225.09
172.69
142.21
164.11
190.95
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
199.77
163.77
225.09
172.69
142.21
164.11
190.95
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
0.11
0.11
0.11
0.12
0.12
0.11
0.0
Reserves
1,734.25
1,629.91
1,810.19
1,778.32
1,595.26
1,385.42
1,292.05
Earnings per share (EPS)
0.36
0.29
0.4
0.31
0.25
0.29
0.34
Diluted Earnings per share
0.36
0.29
0.4
0.31
0.25
0.29
0.34
Operating Profit Margin (Excl OI)
18.45%
16.05%
16.41%
17.86%
16.61%
21.48%
22.17%
Gross Profit Margin
26.59%
26.84%
27.44%
29.22%
27.67%
30.44%
31.75%
PAT Margin
20.91%
17.61%
23.0%
20.31%
20.34%
22.41%
24.89%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 2.74% vs -4.99% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 21.98% vs -27.23% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 14.47% vs -10.02% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 266.67% vs 0.00% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Jilin Province Huinan Changlong Bio Pharmacy Co. Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
Net Sales
955.37
81.46
873.91
1,072.81%
Other Operating Income
0.00
0.00
0.00
Total Operating income
955.37
81.46
873.91
1,072.81%
Raw Material Cost
212.41
42.62
169.79
398.38%
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
117.68
22.07
95.61
433.21%
Power Cost
0
0
0.00
Manufacturing Expenses
2.20
14.06
-11.86
-84.35%
Selling and Distribution Expenses
518.51
75.94
442.57
582.79%
Other Expenses
-7.17
-3.61
-3.56
-98.61%
Total Expenditure (Excl Depreciation)
779.07
118.57
660.50
557.05%
Operating Profit (PBDIT) excl Other Income
176.30
-37.11
213.41
575.07%
Other Income
44.22
4.10
40.12
978.54%
Operating Profit (PBDIT)
249.95
-14.90
264.85
1,777.52%
Interest
2.20
14.06
-11.86
-84.35%
Exceptional Items
6.28
-2.15
8.43
392.09%
Gross Profit (PBDT)
742.96
38.84
704.12
1,812.87%
Depreciation
29.43
18.11
11.32
62.51%
Profit Before Tax
224.61
-49.22
273.83
556.34%
Tax
24.84
-0.06
24.90
41,500.00%
Provisions and contingencies
0
0.00
0.00
Profit After Tax
199.77
-49.49
249.26
503.66%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
199.77
-49.49
249.26
503.66%
Share in Profit of Associates
0
0.00
0.00
Minority Interest
0.00
0.32
-0.32
-100.00%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
199.77
-49.17
248.94
506.28%
Equity Capital
0
0
0.00
Face Value
0.11
0.10
0.00
Reserves
1,734.25
239.38
1,494.87
624.48%
Earnings per share (EPS)
0.36
-0.05
0.41
820.00%
Diluted Earnings per share
0.36
-0.05
0.41
820.00%
Operating Profit Margin (Excl OI)
18.45%
-45.55%
0.00
64.00%
Gross Profit Margin
26.59%
-38.19%
0.00
64.78%
PAT Margin
20.91%
-60.75%
0.00
81.66%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 95.54 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 2.74% vs -4.99% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 19.98 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 21.98% vs -27.23% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 20.57 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 14.47% vs -10.02% in Dec 2023

Annual - Interest
Interest 0.22 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 266.67% vs 0.00% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 18.45%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023